Jennifer Doudna and Feng Zhang have received separate grants from the National Human Genome Research Institute for CRISPR technology-based projects they both say have the potential to advance the tool's usefulness for human health purposes.
UC Berkeley is hosting a two-day conference Aug. 16-17 that will bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leaders and scientists to discuss potential applications of CRISPR technology, ranging from human and animal health to agriculture and...Read more about Aug. 16-17 CRISPRcon to focus on societal issues of gene editing
"It feels a bit like a 'one small step for (hu)mans, one giant leap for (hu)mankind' moment," Jennifer Doudna, a biochemist who helped discover the gene-editing method used, called CRISPR-Cas9, said in an email.